6 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
Translational Research Network in Prostate Cancer (TransPot)
Date du début: 1 janv. 2017, Date de fin: 31 déc. 2020,
The Translational Research Network for Prostate Cancer (TransPot) program adopts an innovative, multidisciplinary approach, providing highly sought-after, effective solutions for incurable prostate cancer (PC).The TransPot scientific objective is to obtain an unmatched depth of molecular, mechanistic and informatics systems-level disease understanding in order to improve the prognosis and treatmen ...
Voir le projet
11
Participants partenaires
TERMINÉ
Protein biomarker for the prediction of response to endocrine treatment in breast cancer patients (EndoPredict)
Date du début: 1 févr. 2013, Date de fin: 31 janv. 2017,
Classical pathologic parameters have been used to inform adjuvant clinical treatment choices for early breast cancer patients. There remain a significant number of patients however, who despite a reportedly favourable prognostic profile, experience metastatic disease. Elucidation of the mechanisms of tumour adaptability and the identification of predictive markers of early recurrence is the basis ...
Voir le projet
2
Participants partenaires
TERMINÉ
Development of an oral Helicobacter Pylori vaccine (HELICOVAXOR)
Date du début: 1 oct. 2012, Date de fin: 31 déc. 2014,
"Helicobacter pylori infection is highly prevalent worldwide and is an important cause of gastritis, peptic ulcer disease, and significantly gastric cancer. Because eradication requires treatment with multidrug regimens, there exists a very strong need for a vaccine to prevent initial infection.Immunization with H pylori protein subunits in humans has shown adjuvant-related adverse effects and onl ...
Voir le projet
11
Participants partenaires
TERMINÉ
Development of OPN-305 as an orphan drug for the treatment of Delayed Graft Function post solid organ transplantation (MABSOT)
Date du début: 1 déc. 2010, Date de fin: 30 sept. 2014,
Delayed graft function (DGF) is defined as the need for dialysis within seven days of renal transplantation (DGF promotes allograft rejection, requires prolonged dialysis and hospitalisation, and increases the likelihood of graft failure and ultimately the duration of renal graft survival-expectancy. The incidence of DGF occurs in 21-44% of cases following cadaveric renal graft. Several rare dise ...
Voir le projet
10
Participants partenaires
TERMINÉ
Identification of Clinically Useful Biomarkers for IGF-I Receptor Signalling n Cancer (BIOMARKERIGF)
Date du début: 1 sept. 2010, Date de fin: 31 août 2014,
...g biomarkers for the IGF-IR signalling pathway in cancer. This programme involves a collaboration between researchers at University College Cork who are experts in IGF-I signalling and researchers at Almac Diagnostics who are experts in pharmacogenomic approaches to biomarker discovery in cancer. The research plan will take two complementary approaches: 1) explore the potential of a list of candid ...
Voir le projet
2
Participants partenaires
TERMINÉ
Understanding inflammation-associated tumorigenesis for the rational design of novel anti-cancer therapeutic strategies (INFLA-CARE)
Date du début: 1 janv. 2009, Date de fin: 30 juin 2013,
Epidemiological and experimental evidence supports a link between chronic inflammation and cancer and indicates a role for inflammatory cells in the initiation, progression and metastasis of malignancy. The objective of the collaborative integrated project INFLA-CARE is to structure a European collective of scientific and technological excellence in the field of ‘Inflammation & Cancer’ which will ...
Voir le projet